Cover Image
市場調查報告書

中風管理的美國市場

U.S. Markets for Stroke Management

出版商 Medtech Insight 商品編碼 338477
出版日期 內容資訊 英文 170 Pages, 44 Exhibits
商品交期: 最快1-2個工作天內
價格
Back to Top
中風管理的美國市場 U.S. Markets for Stroke Management
出版日期: 2015年08月28日 內容資訊: 英文 170 Pages, 44 Exhibits
簡介

美國的中風管理市場預測從2014年到2019年間將以5.1%的年複合成長率成長。就各產品來看各預測年複合成長率,診斷影像產品部門為3.6%,外科、血管相關產品部門市場為5.4%。

本報告提供美國的中風管理市場趨勢相關調查,提供您中風概要,中風的診斷相關產品·介入治療相關產品·藥物種類與概要,治療數量及市場規模的變化與預測,影響市場成長因素分析,彙整美國的主要供應商之市場佔有率,主要供應商的產品系列,新技術分析等相關資訊。

摘要整理

第1章 臨床概要

  • 缺血性中風
    • 症狀與風險因素
    • 一時性缺血性發作
  • 出血性中風
    • 症狀與風險因素
    • 腦動脈瘤
    • 動靜脈畸形

第2章 中風的臨床性管理

  • 中風的診斷·診斷影像
    • CT
    • MRI
    • 診斷超音波
    • 腦血管造影術
    • 核醫學影像
      • 透過迦瑪閃爍攝影機的成像
      • PET
  • 中風的治療管理
    • 藥理的預防·治療模式
      • 抗凝固藥
      • 降壓劑
      • 抗血小板藥
      • 血栓溶解劑
    • 外科介入·血管介入
      • 頸動脈狹窄
      • 顱內動脈瘤·動靜脈畸形
  • 中風的預防·管理新的治療方法
    • 細胞治療
    • Intrasaccular封堵器
    • 超音波血栓溶解
    • Cerebral Collateral Flow Enhancement Systems
    • 神經保護系統
    • 其他血栓溶解劑

第3章 中風管理產品

  • 診斷影像系統
    • CT產品
      • 市場預測
      • 競爭分析
    • MRI產品
      • 市場預測
      • 競爭分析
    • 診斷用超音波產品
      • 市場預測
      • 競爭分析
    • 核醫學影像產品
      • 市場預測
      • 競爭分析
    • 腦血管造影術產品
      • 市場預測
      • 競爭分析
  • 藥物治療產品
    • 口服抗凝固劑
      • 市場預測
    • 口服降壓劑
      • 市場預測
    • 口服抗血小板劑
      • 市場預測
    • 靜脈內血栓溶解劑
      • 市場預測
  • 介入的中風管理系統
    • 中風預防的外科的·血管內系統
      • 頸動脈內薄膜剝離術
      • 頸動脈支架置入
      • 腦動脈瘤/動靜脈畸形的外科夾閉系統
      • 腦動脈瘤/動靜脈畸形的血管栓塞系統
    • 中風管理的腦血管內系統
      • 腦栓塞摘出/機械性血栓摘出產品
      • 顱內支架置入
      • 支流技術

附錄:企業清單

文獻

目錄
Product Code: A226

The United States (U.S.) market for stroke management products, which encompasses diagnostic and therapeutic systems, is a market composed of old and new technologies that are often used together in order to prevent and treat stroke. Improvements in stroke diagnostic systems will facilitate the delivery of timely stroke therapies within the optimum treatment window for patients suffering from stroke. Topics covered in this report include:

  • diagnostic, interventional, and pharmaceutical stroke-related products;
  • procedure and market forecasts for the years 2014 to 2019;
  • key factors influencing the growth of individual product markets;
  • estimated market shares and sales among major U.S. suppliers;
  • major supplier product portfolio analysis in individual product markets; and,
  • emerging technology that could potentially change the way stroke is diagnosed and treated, which could potentially change how product markets develop.

Over the forecast period covered in this report (2014 through 2019), the estimated value of the U.S. market for stroke management systems (not including pharmaceutical agents) is expected to grow by approximately $284.2 million at compound annual growth rate (CAGR) of 5.1%; for the overall stroke management market; diagnostic imaging products are forecasted to grow at a CAGR of 3.6%, while surgical and endovascular products will grow at a CAGR of 5.4%.

Table of Contents

EXECUTIVE SUMMARY

  • i. Methodology

Exhibit ES-1: 2014, U.S. Stroke Management Market, Shares by Product Markets

1. CLINICAL OVERVIEW

  • 1.1 Ischemic Stroke
    • 1.1.1 Symptoms and Risk Factors
    • 1.1.2 Transient Ischemic Attack
  • 1.2 Hemorrhagic Stroke
    • 1.2.1 Symptoms and Risk Factors
    • 1.2.2 Cerebral Aneurysm
    • 1.2.3 Arteriovenous Malformations
  • Exhibit 1-1: 2015, Clinical Features and Characteristics of Ischemic Stroke
  • Exhibit 1-2: 2015, Clinical Features and Characteristics of Hemorrhagic Stroke
  • Exhibit 1-3: 2015, Cerebral Aneurysm, Facts and Figures

2. CLINICAL MANAGEMENT OF STROKE

  • 2.1 Stroke Diagnostics and Diagnostic Imaging
    • 2.1.1 Computed Tomography
      • 2.1.1.1 Stroke-Related Applications of Computed Tomography
    • 2.1.2 Magnetic Resonance Imaging
      • 2.1.2.1 Stroke-Related Applications of Magnetic Resonance Imaging
    • 2.1.3 Diagnostic Ultrasound
      • 2.1.3.1 Stroke-Related Applications of Diagnostic Ultrasound
    • 2.1.4 Cerebral Angiography
      • 2.1.4.1 Stroke-Related Applications of Cerebral Angiography
    • 2.1.5 Nuclear Medicine Imaging
      • 2.1.5.1 Gamma Camera Imaging
      • 2.1.5.2 Positron Emission Tomography
      • 2.1.5.3 Stroke-Related Applications of Nuclear Medicine Imaging
  • 2.2 Therapeutic Management of Stroke
    • 2.2.1 Pharmacologic Preventative and Therapeutic Modalities
      • 2.2.1.1 Anticoagulation Drug Therapy
      • 2.2.1.2 Antihypertensive Drug Therapy
      • 2.2.1.3 Antiplatelet Drug Therapy
      • 2.2.1.4 Thrombolytic Drug Therapy
    • 2.2.2 Surgical and Endovascular Interventions
      • 2.2.2.1 Carotid Artery Stenosis
        • 2.2.2.1.1 Carotid Endarterectomy
        • 2.2.2.1.2 Carotid Artery Stenting
      • 2.2.2.2 Intracranial Aneurysms and Arteriovenous Malformations
        • 2.2.2.2.1 Surgical Repair
        • 2.2.2.2.2 Endovascular Embolization
        • 2.2.2.2.3 Gamma Knife System
        • 2.2.2.2.4 Intracranial Stenting Systems
        • 2.2.2.2.5 Cerebral Thrombectomy Systems
        • 2.2.2.2.6 Flow Diverter Technology
  • 2.3 Emerging Therapies in Stroke Prevention and Management
    • 2.3.1 Cellular Therapy
    • 2.3.2 Intrasaccular Occlusion Devices
    • 2.3.3 Sonothrombolysis
    • 2.3.4 Cerebral Collateral Flow Enhancement Systems
    • 2.3.5 Neuroprotection Systems
    • 2.3.6 Other Thrombolytic Agents
  • Exhibit 2-1: Carotid Endarterectomy
  • Exhibit 2-2: Carotid Artery Stenting
  • Exhibit 2-3: Embolic Coiling
  • Exhibit 2-4: Endovascular Embolization

3. STROKE MANAGEMENT PRODUCTS

  • 3.1 Diagnostic Imaging Systems
    • 3.1.1 Computed Tomography Products
      • 3.1.1.1 Market Forecast
      • 3.1.1.2 Competitive Analysis
    • 3.1.2 Magnetic Resonance Imaging Products
      • 3.1.2.1 Market Forecast
      • 3.1.2.2 Competitive Analysis
    • 3.1.3 Diagnostic Ultrasound Products
      • 3.1.3.1 Market Forecast
      • 3.1.3.2 Competitive Analysis
    • 3.1.4 Nuclear Medicine Imaging Products
      • 3.1.4.1 Market Forecast
      • 3.1.4.2 Competitive Analysis
    • 3.1.5 Cerebral Angiography Products
      • 3.1.5.1 Market Forecast
      • 3.1.5.2 Competitive Analysis
  • 3.2 Drug Therapy Products
    • 3.2.1 Oral Anticoagulation Agents
      • 3.2.1.1 Market Forecast
    • 3.2.2 Oral Antihypertensive Agents
      • 3.2.2.1 Market Forecast
    • 3.2.3 Oral Antiplatelet Agents
      • 3.2.3.1 Market Forecast
    • 3.2.4 Intravenous Thrombolytic Agents
      • 3.2.4.1 Market Forecast
  • 3.3 Interventional Stroke Management Systems
    • 3.3.1 Surgical and Endovascular Systems for Stroke Prophylaxis
      • 3.3.1.1 Carotid Endarterectomy
        • 3.3.1.1.1 Market Forecast
      • 3.3.1.2 Carotid Artery Stenting
        • 3.3.1.2.1 Market Forecast
        • 3.3.1.2.2 Competitive Analysis
      • 3.3.1.3 Cerebral Aneurysm/Arteriovenous Malformation Surgical Clipping Systems
        • 3.3.1.3.1 Market Forecast
        • 3.3.1.3.2 Competitive Analysis
      • 3.3.1.4 Cerebral Aneurysm/Arteriovenous Malformation Endovascular Embolization Systems
        • 3.3.1.4.1 Market Forecast
        • 3.3.1.4.2 Competitive Analysis
    • 3.3.2 Cerebrovascular Endovascular Systems for Stroke Treatment
      • 3.3.2.1 Cerebral Embolectomy/Mechanical Thrombectomy Products
        • 3.3.2.1.1 Market Forecast
        • 3.3.2.1.2 Competitive Analysis
        • 3.3.2.1.3 Emerging Cerebral Thrombectomy Systems
      • 3.3.2.2 Intracranial Stenting Systems
        • 3.3.2.2.1 Market Forecast
      • 3.3.2.3 Flow Diverter Technology
        • 3.3.2.3.1 Market Forecast
        • 3.3.2.3.2 Competitive Analysis
  • Exhibit 3-1: Stroke Management Products, Combined Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-2: Stroke Management Products, Combined Market Forecast, 2014-2019
  • Exhibit 3-3: Stroke Diagnostic Imaging, Combined Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-4: Stroke Diagnostic Imaging Products, Combined Market Forecast, 2014-2019
  • Exhibit 3-5: Computed Tomography, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-6: Computed Tomography, Market Forecast, 2014-2019
  • Exhibit 3-7: 2014, Computed Tomography Systems Market, Share by Supplier
  • Exhibit 3-8: Magnetic Resonance Imaging, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-9: Magnetic Resonance Imaging, Market Forecast, 2014-2019
  • Exhibit 3-10: 2014, Magnetic Resonance Imaging Systems Market, Share by Supplier
  • Exhibit 3-11: Diagnostic Ultrasound Imaging, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-12: Diagnostic Ultrasound Imaging Systems, Market Forecast, 2014-2019
  • Exhibit 3-13: 2014, Diagnostic Ultrasound Imaging Systems Market, Share by Supplier
  • Exhibit 3-14: Nuclear Medicine Imaging, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-15: Nuclear Medicine Imaging Systems, Market Forecast, 2014-2019
  • Exhibit 3-16: 2014, Nuclear Medicine Imaging Systems Market, Share
  • by Supplier
  • Exhibit 3-17: Cerebral Angiography, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-18: Cerebral Angiography Devices, Market Forecast, 2014-2019
  • Exhibit 3-19: 2014, Coronary Angiography Devices Market, Share by Supplier
  • Exhibit 3-20: Stroke-related Surgical and Endovascular Therapies, Combined Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-21: Stroke-related Surgical and Endovascular Therapies, Combined Market Forecast, 2014-2019
  • Exhibit 3-22: Carotid Endarterectomy, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-23: Carotid Endarterectomy, Market Forecast, 2014-2019
  • Exhibit 3-24: Distally Protected Carotid Artery Stenting, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-25: Distally Protected Carotid Artery Stenting, Market Forecast, 2014-2019
  • Exhibit 3-26: 2014, Distally Protected Carotid Artery Stenting Systems Market, Share by Supplier
  • Exhibit 3-27: Cerebral Aneurysm and Surgical AVM Repair, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-28: Cerebral Aneurysm and Surgical AVM Repair, Market Forecast, 2014-2019
  • Exhibit 3-29: 2014, Cerebral Aneurysm/AVM Clip Systems Market, Share by Supplier
  • Exhibit 3-30: Cerebral Aneurysm & AVM Endovascular Embolization, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-31: Cerebral Aneurysm & AVM Endovascular Embolization, Market Forecast, 2014-2019
  • Exhibit 3-32: 2014, Cerebral Aneurysm & AVM Endovascular Embolization Systems Market, Share by Supplier
  • Exhibit 3-33: Cerebral Thrombectomy, Procedure Volumes Forecast, 2014-2019
  • Exhibit 3-34: Cerebral Thrombectomy, Market Forecast, 2014-2019
  • Exhibit 3-35: 2014, Cerebral Thrombectomy Systems Market, Share by Supplier
  • Exhibit 3-36: Intracranial Stenting, Market Forecast, 2014-2019

APPENDIX: COMPANY LISTING

BIBLIOGRAPHY

Back to Top